title: Electroacupuncture analgesia in rats: naltrexone antagonism is dependent on previous exposure.
abstract: Inhibition of pain by low frequency electroacupuncture (EA) has been thought to be mediated by endogenous opioids. We reported in a previous paper, however, that naloxone (NAL) and naltrexone (NTX) either potentiated or had no effect on analgesia in EA-naive rats, independent of origin (American or Chinese), sex, weight, geographic location (the U.S.A. or China), or numerous variations of experimental methodology. In the present study, we hypothesized that the number of exposures to EA treatment may be responsible for the discrepant effect of opiate antagonists. We found, as previously demonstrated, analgesia in EA-naive rats was potentiated by NTX. After two pre-exposures to EA, however, NTX antagonized analgesia. These results indicate that, in rats: (1) pre-exposure is a key variable for opiate antagonists to produce antagonism or potentiation of analgesia; (2) environmental cues paired with the initial analgesic manipulation may be responsible for converting analgesia from non-opioid to opioid, as already demonstrated with classically conditioned and learned helplessness induced analgesia; and (3) EA analgesia in rats is a multidimensional manipulation which can be influenced by subtle environmental changes.
authors.affiliation: Department of Physiology, Medical College of Virginia, Virginia Commonwealth University, Richmond 23298.
authors.forename: D F
authors.initials: DF
authors.lastname: Bossut
authors.forename: D J
authors.initials: DJ
authors.lastname: Mayer
mesh_terms: D000698:Analgesia; D000704:Analysis of Variance; D000818:Animals; D002681:China; D015671:Electroacupuncture; D008297:Male; D009270:Naloxone / Q000494:pharmacology*; D009271:Naltrexone / Q000494:pharmacology*; D010146:Pain / Q000503:physiopathology*; D059408:Pain Management; D051381:Rats; D011919:Rats, Inbred Strains; D013045:Species Specificity; D013997:Time Factors; D014481:United States
chemical_list: D009270:Naloxone; D009271:Naltrexone